NCT06516744

Brief Summary

This virtual single-group study aims to evaluate the efficacy of Bye Bye Bloat Capsules in relieving hormonal and food-related bloating and promoting healthy digestion. The study will last 4 weeks, involving 40 female participants aged 18+ who will take two capsules after meals and during times of bloating. Measurements and questionnaires will be completed at Baseline, first use, Week 2, and Week 4.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 8, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 20, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 20, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 11, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

July 24, 2024

Completed
Last Updated

July 24, 2024

Status Verified

July 1, 2024

Enrollment Period

2 months

First QC Date

July 11, 2024

Last Update Submit

July 17, 2024

Conditions

Keywords

Gastrointestinal SymptomsHormonal BloatingCapsule Supplement

Outcome Measures

Primary Outcomes (1)

  • Reduction in Bloating

    Evaluation of parameters associated with hormonal and food-related bloating through self-reported questionnaires taken at Baseline, first use, Week 2, and Week 4.

    Baseline, first use, Week 2, and Week 4

Secondary Outcomes (1)

  • Improvement in Digestion and Mental Well-being

    Baseline, first use, Week 2, and Week 4

Study Arms (1)

Bye Bye Bloat Capsules

EXPERIMENTAL

Participants will take 2 Bye Bye Bloat capsules immediately after eating (when they feel full and bloated) at least 3 times a week. They may also take the product during times of hormonal bloating. The study will last for 4 weeks, with questionnaires and waist measurements completed at Baseline, first use, Week 2, and Week 4.

Dietary Supplement: Bye Bye Bloat Capsules

Interventions

Bye Bye Bloat CapsulesDIETARY_SUPPLEMENT

Bye Bye Bloat Capsules contain the following ingredients: Organic Fenugreek Seed Powder, Organic Dandelion Root Powder, Organic Fennel Seed Powder, Organic Ginger Root Powder, Organic Parsley Leaf Powder, Amylase Complex, Protease Complex, Pepsin Complex, Lipase Complex, Bromelain Complex, Papain Complex. Other ingredients include Hypromellose Capsule, Maltodextrin, Microcrystalline Cellulose, and Magnesium Stearate. Participants will take 2 capsules immediately after eating at least 3 times a week and during times of hormonal bloating for 4 weeks.

Bye Bye Bloat Capsules

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women aged 18+
  • Self-reported concerns with bloating after eating
  • Issues with hormonal bloating
  • Generally healthy without uncontrolled chronic diseases
  • Willing to avoid using digestive health remedies and other oral supplements during the study

You may not qualify if:

  • Pre-existing chronic conditions preventing adherence to the protocol
  • Undergoing procedures related to digestive health
  • Started new medications or supplements targeting digestive health in the past 3 months
  • Severe allergic reactions requiring an Epi-Pen
  • Pregnant, breastfeeding, or attempting to conceive
  • Unwilling to follow the study protocol
  • Recent surgeries or planned surgeries during the study
  • Diagnosed gastrointestinal disorders
  • Recent changes in hormonal birth control use

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Citruslabs

Santa Monica, California, 90404, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 11, 2024

First Posted

July 24, 2024

Study Start

February 8, 2024

Primary Completion

April 20, 2024

Study Completion

April 20, 2024

Last Updated

July 24, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations